Skip to main content
Loading
Lingbing Zhang

Lingbing Zhang

CEO, Yinuoke
United States
Dr. Zhang graduated from Jilin University with a doctoral degree in immunology. From 2008 to 2012, Dr. Zhang did a postdoctoral fellowship at Stanford University studying cancer immunology and immunotherapy. After the postdoctoral fellowship, Dr.Zhang continued to study cancer immunology at Stanford University focusing on the immune system dynamics underlying cancer development and its impact on the host. In 2016, Dr.Zhang founded Yinuoke to discover and develop innovative medicines based on insights from decade-long experience of cancer research.
Sessions
  • 17-Oct-2023
    Franciscan C
    Yinuoke